The whole genome sequencing market size was estimated at US$ 6.16 billion in 2022 it is predicted to grow at a CAGR of 18.4% from 2023 to 2032 to reach around US$ 33.33 billion by the end of 2032.
The whole genome sequencing market report offers an exclusive study of the present state expected at the market dynamics, opportunities, market scheme, growth analysis and regional outlook. The report presents energetic visions to conclude and study the market size, market aspiration, and competitive environment. The research also focuses on the important achievements of the market, research & development, and regional (country by country) growth of the leading vendors operating in the market
The study offers intricate dynamics about different aspects of the global whole genome sequencing market, which aids companies operating in the market in making strategies development decisions. The study also elaborates on remarkable changes that are highly anticipated to configure growth of the global whole genome sequencing market during the forecast period. It also includes a key indicator analysis that highlights growth prospects of this market and approximate statistics related to growth of the market in terms of value (US$ Bn) and volume (tons).
Sample Link @ https://www.visionresearchreports.com/report/sample/40037
Report Scope of the Whole Genome Sequencing Market
| Report Coverage | Details |
| Market Size in 2022 | USD 6.16 billion |
| Revenue Forecast by 2032 | USD 33.33 billion |
| Growth rate from 2023 to 2032 | CAGR of 18.4% |
| Base Year | 2022 |
| Forecast Period | 2023 to 2032 |
| Regions Covered | North America, Europe, Asia Pacific, Latin America, Middle East & Africa |
| Companies Covered | GE Healthcare, Thermo Fisher Scientific, Inc., Illumina, Inc., QIAGEN N.V., Agilent Technologies, 10 x Genomics, BGI, Oxford Nanopore, Nebula Genomics, Veritas Genetics, and GENEWIZ amongst others. |
This study covers an elaborate segmentation of the global whole genome sequencing market, along with important information and a competition outlook. The report mentions company profiles of players that are currently influence the global whole genome sequencing market, wherein various developments, expansions, and winning strategies practiced and execute by leading players have been presented in detail.
Whole Genome Sequencing Market Segmentations:
| By Sequencing Type | By Product Type | By Application | By End User |
| Large Whole-Genome Sequencing
Small Genome Sequencing |
Instrument
Kits Service |
Diagnostics
Drug Discovery and Development Personalized Medicine Others |
Hospitals and Clinics
Pharmaceutical and Biotechnology Companies Others |
Research Methodology
The research methodology acquire by analysts for assemble the global whole genome sequencing market report is based on detailed primary as well as secondary research. With the help of in-depth insights of the market-affiliated information that is obtained and legitimated by market-admissible resources, analysts have offered riveting observations and authentic forecasts for the global market.
During the primary research phase, analysts interviewed market stakeholders, investors, brand managers, vice presidents, and sales and marketing managers. Based on data obtained through interviews of genuine resources, analysts have emphasized the changing scenario of the global market.
For secondary research, analysts study numerous annual report declaration, white papers, market association declaration, and company websites to obtain the necessary understanding of the global whole genome sequencing market.
TABLE OF CONTENT
Chapter 1. Introduction
1.1. Research Objective
1.2. Scope of the Study
1.3. Definition
Chapter 2. Research Methodology
2.1. Research Approach
2.2. Data Sources
2.3. Assumptions & Limitations
Chapter 3. Executive Summary
3.1. Market Snapshot
Chapter 4. Market Variables and Scope
4.1. Introduction
4.2. Market Classification and Scope
4.3. Industry Value Chain Analysis
4.3.1. Raw Material Procurement Analysis
4.3.2. Sales and Distribution Channel Analysis
4.3.3. Downstream Buyer Analysis
Chapter 5. COVID 19 Impact on Whole Genome Sequencing Market
5.1. COVID-19 Landscape: Whole Genome Sequencing Industry Impact
5.2. COVID 19 – Impact Assessment for the Industry
5.3. COVID 19 Impact: Global Major Government Policy
5.4. Market Trends and Opportunities in the COVID-19 Landscape
Chapter 6. Market Dynamics Analysis and Trends
6.1. Market Dynamics
6.1.1. Market Drivers
6.1.2. Market Restraints
6.1.3. Market Opportunities
6.2. Porter’s Five Forces Analysis
6.2.1. Bargaining power of suppliers
6.2.2. Bargaining power of buyers
6.2.3. Threat of substitute
6.2.4. Threat of new entrants
6.2.5. Degree of competition
Chapter 7. Competitive Landscape
7.1.1. Company Market Share/Positioning Analysis
7.1.2. Key Strategies Adopted by Players
7.1.3. Vendor Landscape
7.1.3.1. List of Suppliers
7.1.3.2. List of Buyers
Chapter 8. Global Whole Genome Sequencing Market, By Sequencing Type
8.1. Whole Genome Sequencing Market, by Sequencing Type, 2023-2032
8.1.1. Large Whole-Genome Sequencing
8.1.1.1. Market Revenue and Forecast (2020-2032)
8.1.2. Small Genome Sequencing
8.1.2.1. Market Revenue and Forecast (2020-2032)
Chapter 9. Global Whole Genome Sequencing Market, By Product Type
9.1. Whole Genome Sequencing Market, by Product Type, 2023-2032
9.1.1. Instrument
9.1.1.1. Market Revenue and Forecast (2020-2032)
9.1.2. Kits
9.1.2.1. Market Revenue and Forecast (2020-2032)
9.1.3. Service
9.1.3.1. Market Revenue and Forecast (2020-2032)
Chapter 10. Global Whole Genome Sequencing Market, By Application
10.1. Whole Genome Sequencing Market, by Application, 2023-2032
10.1.1. Diagnostics
10.1.1.1. Market Revenue and Forecast (2020-2032)
10.1.2. Drug Discovery and Development
10.1.2.1. Market Revenue and Forecast (2020-2032)
10.1.3. Personalized Medicine
10.1.3.1. Market Revenue and Forecast (2020-2032)
10.1.4. Others
10.1.4.1. Market Revenue and Forecast (2020-2032)
Chapter 11. Global Whole Genome Sequencing Market, By Hospitals and Clinics
11.1. Whole Genome Sequencing Market, by End User, 2023-2032
11.1.1. Hospitals and Clinics
11.1.1.1. Market Revenue and Forecast (2020-2032)
11.1.2. Pharmaceutical and Biotechnology Companies
11.1.2.1. Market Revenue and Forecast (2020-2032)
11.1.3. Others
11.1.3.1. Market Revenue and Forecast (2020-2032)
Chapter 12. Global Whole Genome Sequencing Market, Regional Estimates and Trend Forecast
12.1. North America
12.1.1. Market Revenue and Forecast, by Sequencing Type (2020-2032)
12.1.2. Market Revenue and Forecast, by Product Type (2020-2032)
12.1.3. Market Revenue and Forecast, by Application (2020-2032)
12.1.4. Market Revenue and Forecast, by End User (2020-2032)
12.1.5. U.S.
12.1.5.1. Market Revenue and Forecast, by Sequencing Type (2020-2032)
12.1.5.2. Market Revenue and Forecast, by Product Type (2020-2032)
12.1.5.3. Market Revenue and Forecast, by Application (2020-2032)
12.1.5.4. Market Revenue and Forecast, by End User (2020-2032)
12.1.6. Rest of North America
12.1.6.1. Market Revenue and Forecast, by Sequencing Type (2020-2032)
12.1.6.2. Market Revenue and Forecast, by Product Type (2020-2032)
12.1.6.3. Market Revenue and Forecast, by Application (2020-2032)
12.1.6.4. Market Revenue and Forecast, by End User (2020-2032)
12.2. Europe
12.2.1. Market Revenue and Forecast, by Sequencing Type (2020-2032)
12.2.2. Market Revenue and Forecast, by Product Type (2020-2032)
12.2.3. Market Revenue and Forecast, by Application (2020-2032)
12.2.4. Market Revenue and Forecast, by End User (2020-2032)
12.2.5. UK
12.2.5.1. Market Revenue and Forecast, by Sequencing Type (2020-2032)
12.2.5.2. Market Revenue and Forecast, by Product Type (2020-2032)
12.2.5.3. Market Revenue and Forecast, by Application (2020-2032)
12.2.5.4. Market Revenue and Forecast, by End User (2020-2032)
12.2.6. Germany
12.2.6.1. Market Revenue and Forecast, by Sequencing Type (2020-2032)
12.2.6.2. Market Revenue and Forecast, by Product Type (2020-2032)
12.2.6.3. Market Revenue and Forecast, by Application (2020-2032)
12.2.6.4. Market Revenue and Forecast, by End User (2020-2032)
12.2.7. France
12.2.7.1. Market Revenue and Forecast, by Sequencing Type (2020-2032)
12.2.7.2. Market Revenue and Forecast, by Product Type (2020-2032)
12.2.7.3. Market Revenue and Forecast, by Application (2020-2032)
12.2.7.4. Market Revenue and Forecast, by End User (2020-2032)
12.2.8. Rest of Europe
12.2.8.1. Market Revenue and Forecast, by Sequencing Type (2020-2032)
12.2.8.2. Market Revenue and Forecast, by Product Type (2020-2032)
12.2.8.3. Market Revenue and Forecast, by Application (2020-2032)
12.2.8.4. Market Revenue and Forecast, by End User (2020-2032)
12.3. APAC
12.3.1. Market Revenue and Forecast, by Sequencing Type (2020-2032)
12.3.2. Market Revenue and Forecast, by Product Type (2020-2032)
12.3.3. Market Revenue and Forecast, by Application (2020-2032)
12.3.4. Market Revenue and Forecast, by End User (2020-2032)
12.3.5. India
12.3.5.1. Market Revenue and Forecast, by Sequencing Type (2020-2032)
12.3.5.2. Market Revenue and Forecast, by Product Type (2020-2032)
12.3.5.3. Market Revenue and Forecast, by Application (2020-2032)
12.3.5.4. Market Revenue and Forecast, by End User (2020-2032)
12.3.6. China
12.3.6.1. Market Revenue and Forecast, by Sequencing Type (2020-2032)
12.3.6.2. Market Revenue and Forecast, by Product Type (2020-2032)
12.3.6.3. Market Revenue and Forecast, by Application (2020-2032)
12.3.6.4. Market Revenue and Forecast, by End User (2020-2032)
12.3.7. Japan
12.3.7.1. Market Revenue and Forecast, by Sequencing Type (2020-2032)
12.3.7.2. Market Revenue and Forecast, by Product Type (2020-2032)
12.3.7.3. Market Revenue and Forecast, by Application (2020-2032)
12.3.7.4. Market Revenue and Forecast, by End User (2020-2032)
12.3.8. Rest of APAC
12.3.8.1. Market Revenue and Forecast, by Sequencing Type (2020-2032)
12.3.8.2. Market Revenue and Forecast, by Product Type (2020-2032)
12.3.8.3. Market Revenue and Forecast, by Application (2020-2032)
12.3.8.4. Market Revenue and Forecast, by End User (2020-2032)
12.4. MEA
12.4.1. Market Revenue and Forecast, by Sequencing Type (2020-2032)
12.4.2. Market Revenue and Forecast, by Product Type (2020-2032)
12.4.3. Market Revenue and Forecast, by Application (2020-2032)
12.4.4. Market Revenue and Forecast, by End User (2020-2032)
12.4.5. GCC
12.4.5.1. Market Revenue and Forecast, by Sequencing Type (2020-2032)
12.4.5.2. Market Revenue and Forecast, by Product Type (2020-2032)
12.4.5.3. Market Revenue and Forecast, by Application (2020-2032)
12.4.5.4. Market Revenue and Forecast, by End User (2020-2032)
12.4.6. North Africa
12.4.6.1. Market Revenue and Forecast, by Sequencing Type (2020-2032)
12.4.6.2. Market Revenue and Forecast, by Product Type (2020-2032)
12.4.6.3. Market Revenue and Forecast, by Application (2020-2032)
12.4.6.4. Market Revenue and Forecast, by End User (2020-2032)
12.4.7. South Africa
12.4.7.1. Market Revenue and Forecast, by Sequencing Type (2020-2032)
12.4.7.2. Market Revenue and Forecast, by Product Type (2020-2032)
12.4.7.3. Market Revenue and Forecast, by Application (2020-2032)
12.4.7.4. Market Revenue and Forecast, by End User (2020-2032)
12.4.8. Rest of MEA
12.4.8.1. Market Revenue and Forecast, by Sequencing Type (2020-2032)
12.4.8.2. Market Revenue and Forecast, by Product Type (2020-2032)
12.4.8.3. Market Revenue and Forecast, by Application (2020-2032)
12.4.8.4. Market Revenue and Forecast, by End User (2020-2032)
12.5. Latin America
12.5.1. Market Revenue and Forecast, by Sequencing Type (2020-2032)
12.5.2. Market Revenue and Forecast, by Product Type (2020-2032)
12.5.3. Market Revenue and Forecast, by Application (2020-2032)
12.5.4. Market Revenue and Forecast, by End User (2020-2032)
12.5.5. Brazil
12.5.5.1. Market Revenue and Forecast, by Sequencing Type (2020-2032)
12.5.5.2. Market Revenue and Forecast, by Product Type (2020-2032)
12.5.5.3. Market Revenue and Forecast, by Application (2020-2032)
12.5.5.4. Market Revenue and Forecast, by End User (2020-2032)
12.5.6. Rest of LATAM
12.5.6.1. Market Revenue and Forecast, by Sequencing Type (2020-2032)
12.5.6.2. Market Revenue and Forecast, by Product Type (2020-2032)
12.5.6.3. Market Revenue and Forecast, by Application (2020-2032)
12.5.6.4. Market Revenue and Forecast, by End User (2020-2032)
Chapter 13. Company Profiles
13.1. GE Healthcare
13.1.1. Company Overview
13.1.2. Product Offerings
13.1.3. Financial Performance
13.1.4. Recent Initiatives
13.2. Thermo Fisher Scientific, Inc.
13.2.1. Company Overview
13.2.2. Product Offerings
13.2.3. Financial Performance
13.2.4. Recent Initiatives
13.3. Illumina, Inc.
13.3.1. Company Overview
13.3.2. Product Offerings
13.3.3. Financial Performance
13.3.4. Recent Initiatives
13.4. QIAGEN N.V.
13.4.1. Company Overview
13.4.2. Product Offerings
13.4.3. Financial Performance
13.4.4. Recent Initiatives
13.5. Agilent Technologies
13.5.1. Company Overview
13.5.2. Product Offerings
13.5.3. Financial Performance
13.5.4. Recent Initiatives
13.6. 10 x Genomics
13.6.1. Company Overview
13.6.2. Product Offerings
13.6.3. Financial Performance
13.6.4. Recent Initiatives
13.7. BGI
13.7.1. Company Overview
13.7.2. Product Offerings
13.7.3. Financial Performance
13.7.4. Recent Initiatives
13.8. Oxford Nanopore
13.8.1. Company Overview
13.8.2. Product Offerings
13.8.3. Financial Performance
13.8.4. Recent Initiatives
13.9. Nebula Genomics
13.9.1. Company Overview
13.9.2. Product Offerings
13.9.3. Financial Performance
13.9.4. Recent Initiatives
13.10. Veritas Genetics
13.10.1. Company Overview
13.10.2. Product Offerings
13.10.3. Financial Performance
13.10.4. Recent Initiatives
Chapter 14. Research Methodology
14.1. Primary Research
14.2. Secondary Research
14.3. Assumptions
Chapter 15. Appendix
15.1. About Us
15.2. Glossary of Terms
Contact Us:
Vision Research Reports
Apt 1408 1785 Riverside Drive Ottawa, ON, K1G 3T7, Canada
Call: +1 774 402 6168